Investor Stock List
Ranked #4,683 of 8,699 institutional investors

Great Point Partners LLC

Greenwich, CT

$334M
US stock portfolio at live prices · today −$390K (−0.12%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$381M
Change from Q2 2026
−$43.5M (−10.25%)
Positions
32 · 5 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $4.4M of stock, put options on $33.1M. $66.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
GMAB 8.07%VERA 6.48%VOR 6.25%SGMT 5.65%AMLX 5.49%
StockSharesValue, live% of portfoliovs Q2 2026
GMAB Genmab A/S525,000$27.0M8.07%New
VERA Vera Therapeutics, Inc.808,717$21.6M6.48%Added +35%
VOR Vor Biopharma Inc.1,126,910$20.9M6.25%Reduced −34%
SGMT Sagimet Biosciences Inc.1,961,701$18.9M5.65%Reduced −3%
AMLX Amylyx Pharmaceuticals, Inc.700,000$18.3M5.49%Unchanged
LBRX LB Pharmaceuticals Inc410,420$16.4M4.92%Added +29%
DFTX Definium Therapeutics, Inc.508,735$15.0M4.49%Added +20%
ABVX ABIVAX Société Anonyme155,000$12.5M3.74%Reduced −24%
ANNX Annexon, Inc.3,500,000$11.9M3.57%Unchanged
IONS Ionis Pharmaceuticals, Inc.420,000$11.4M3.42%New
BLTE Belite Bio, Inc75,000$11.3M3.39%New
MLTX MoonLake Immunotherapeutics855,813$9.4M2.83%Unchanged
CLYM Climb Bio Inc800,000$7.4M2.22%Reduced −20%
EPRX Eupraxia Pharmaceuticals Inc.1,200,000$7.3M2.20%Unchanged
NGNE Neurogene Inc.300,000$6.9M2.06%Reduced −15%
ABCL AbCellera Biologics Inc.600,000$6.3M1.88%New
NKTR Nektar Therapeutics175,000$5.7M1.71%Unchanged
CMPS COMPASS Pathways plc500,000$4.3M1.30%New
RZLT Rezolute, Inc.951,809$4.0M1.20%Unchanged
ELVN Enliven Therapeutics, Inc.70,000$3.2M0.97%Unchanged
IRD Opus Genetics, Inc.776,881$3.2M0.95%Reduced −61%
CGEM Cullinan Therapeutics, Inc.300,000$2.7M0.81%Unchanged
RLMD Relmada Therapeutics, Inc.842,106$2.6M0.78%Unchanged
SCYX SCYNEXIS, Inc.944,292$2.5M0.74%Unchanged
ALT Altimmune, Inc.1,741,232$2.5M0.74%Unchanged
ORKA Oruka Therapeutics, Inc.24,649$2.4M0.72%Reduced −87%
DBVT DBV Technologies S.A.250,000$2.4M0.71%Added +59%
EVMN Evommune Inc325,000$2.4M0.70%Unchanged
DRUG Bright Minds Biosciences Inc.109,603$2.3M0.68%Unchanged
HUMA Humacyte, Inc.3,750,000$2.0M0.61%Unchanged
CTNM Contineum Therapeutics, Inc.186,183$1.7M0.50%Reduced −80%
RNTX Rein Therapeutics Inc.1,663,144$612K0.18%Reduced −35%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
IMMX Immix Biopharma, Inc.1,277,642$9.0M
SLN Silence Therapeutics plc450,000$8.9M
ALMS Alumis Inc.856,061$3.7M
PALI Palisade Bio, Inc.2,284,819$2.1M
PMN ProMIS Neurosciences, Inc.86,150$277K